CYCN
Cyclerion Therapeutics Inc
NASDAQ: CYCN · HEALTHCARE · BIOTECHNOLOGY
$3.31
-0.30% today
Updated 2026-04-30
Market cap
$12.73M
P/E ratio
—
P/S ratio
6.14x
EPS (TTM)
$-1.11
Dividend yield
—
52W range
$1 – $8
Volume
5.6M
Cyclerion Therapeutics Inc (CYCN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $4.51M | $2.30M | $3.32M | $297000.00 | $0.00 | $2.00M | $2.07M |
| Revenue growth (YoY) | — | — | — | — | -49.1% | +44.6% | -91.1% | -100.0% | — | +3.7% |
| Cost of revenue | $2.17M | $1.75M | $1.53M | $95.14M | $56.41M | $472000.00 | $5.58M | — | — | — |
| Gross profit | $-2.17M | $-1.75M | $-1.53M | $-90.63M | $-54.12M | $3.32M | $-5.28M | — | $2.00M | $2.07M |
| Gross margin | — | — | — | -2010.9% | -2357.1% | 100.0% | -1778.5% | — | 100.0% | 100.0% |
| R&D | $50.90M | $78.80M | $87.72M | $95.14M | $56.41M | $37.64M | $5.98M | $1.51M | $286000.00 | $959000.00 |
| SG&A | $12.65M | $15.12M | $27.54M | $34.40M | $28.82M | $20.62M | $12.86M | $8.13M | $5.34M | $6.09M |
| Operating income | $-63.55M | $-93.92M | $-115.25M | $-125.04M | $-81.27M | $-55.20M | $-18.54M | $-12.95M | $-3.63M | $-4.97M |
| Operating margin | — | — | — | -2774.3% | -3539.4% | -1662.5% | -6242.4% | — | -181.4% | -239.8% |
| EBITDA | $-61.38M | $-92.18M | $-113.72M | $-122.34M | $-80.64M | $-53.84M | $-18.48M | $-9.58M | $-3.63M | $-4.97M |
| EBITDA margin | — | — | — | -2714.4% | -3512.1% | -1621.7% | -6220.5% | — | -181.4% | -239.8% |
| EBIT | $-63.55M | $-93.92M | $-115.25M | $-125.04M | $-82.93M | $-54.31M | $-18.54M | $-9.65M | $-3.63M | — |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $588000.00 | $16000.00 | $294000.00 | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-63.55M | $-93.92M | $-115.25M | $-123.01M | $-77.80M | $-51.65M | $-44.08M | $-5.26M | $-3.06M | $-3.53M |
| Net income growth (YoY) | — | -47.8% | -22.7% | -6.7% | +36.8% | +33.6% | +14.7% | +88.1% | +41.9% | -15.4% |
| Profit margin | — | — | — | -2729.3% | -3388.6% | -1555.6% | -14841.1% | — | -152.8% | -170.1% |